|
KMID : 0941820110210040347
|
|
Korean Journal of Clinical Pharmacy
2011 Volume.21 No. 4 p.347 ~ p.352
|
|
|
Impact and Barriers of the Health Insurance Review on Splitting Extended-Release Formulation Drugs
|
|
Jang Hye-Min
Lee Eui-Kyung
|
|
|
Abstract
|
|
|
|
Health insurance review & Assessment service (HIRA) has enforced cutting the drug costs when physicians prescribe split extended release drugs, starting from December, 2010. The objective of this study is to analyze extended release and enteric coated drugs on pharmaceutical reimbursement list in Korea, and to investigate the impact and barriers of the health insurance review on splitting extended-release formulation drugs. By using the ingredient code, extended release and enteric coated formulations make up 7.8% of all drugs in April, 2011. The most frequently used drugs are agent affecting circulatory and digestive system. From the extended release and enteric coated formulations (n=112), 34.8% (n=39) were not available in other dosage forms. According to questionnaire survey for 169 pharmacists (response rate: 73.8%), the rate of splitting and crushing of extended release and enteric coated drugs decreased. When pharmacists correct physician’s prescription errors, the biggest problem was lack of other dosage forms. So it is necessary to develop variety of other dosage forms, and computerized checking system for splitting extended-release drugs. It is also important to inform physicians and patients in regard to the problems of split prescription of extended release and enteric coated drugs.
|
|
|
KEYWORD
|
|
|
extended release, splitting, health insurance review
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|